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Pelvic Examinations for Ovarian Cancer Screening in Asymptomatic Adult Women
Riann Collar, PA-S
Department of Physician Assistant Studies, University of North Dakota, School of Medicine & Health Sciences
• Prior to 2013, Pap testing was performed annually for cervical cancer 
screening and typically a pelvic examination would be performed in 
addition to a Pap every year
• In 2013, the American College of Obstetricians and Gynecologists 
(ACOG) changed the recommendations for performing Pap testing from 
annually to every 3 years alone or 5 years if co-testing with HPV
• It is not clearly defined if pelvic examinations should be continued 
annually for ovarian cancer screening 
• The U.S. Preventive Services Task Force (USPSTF) states:
– there is not enough evidence to be for or against routine 
screening with pelvic examination
– unsure of the benefits versus the harms because of the lack 
of studies
– has not given a recommendation with a Grade I for 
insufficient evidence (USPSTF, 2017) 
• The American Academy of Family Physicians (AAFP) 
recommends against pelvic exams
– Grade D for evidence of little benefit and possible harm 
(AAFP, 2017)
• ACOG  recommends annual pelvic exams at well-woman visits 
based on expert opinion, discussion should be had between 
patient/provider and come to a shared decision (ACOG, 2016) 
• Overall, current evidence that supports performing pelvic 
examinations is not strong and is outdated
• Ovarian cancer is usually detected late with a low 5-year 
survival prognosis, and if bimanual exams may find some of 
these cases earlier, it is worth performing
• Pelvic exams have a high benign findings rate which can lead 
to additional cost, testing, anxiety, and possibly unnecessary 
surgery, however, these are necessary to find some cases of 
ovarian cancer early
• All studies reviewed that were conducted to evaluate 
provider’s practices and beliefs show that the majority of 
providers, especially OB/GYN, still feel bimanual pelvic exams 
are an important part of the well-woman visit
• Combining different screening methods (serum CA-125, TVU, 
pelvic exam) for ovarian cancer has proven to be effective but 
cost was not considered, further study needs to be completed 
and insurance coverage would be necessary for other 
screening methods
There is discrepancy amongst organizations and the medical community 
whether bimanual pelvic examinations should be performed in 
asymptomatic women for routine screening. The purpose of this literature 
review was to determine whether bimanual pelvic examinations are 
beneficial for screening for ovarian cancer in comparison to no screening. 
In addition, research was conducted to see if healthcare providers’ 
professional beliefs align with the evidence and national 
recommendations, to determine women’s thoughts and beliefs regarding 
pelvic examinations, and identify other screening methods if bimanual 
pelvic exams are determined to be an invalid screening tool. Throughout 
reviewing peer reviewed articles and high-quality evidence, it was found 
that bimanual pelvic exams have low sensitivity for screening, which is not 
ideal due to false positives; however, several researchers still feel this is 
an important screening tool. Also, many providers still consider the pelvic 
exam beneficial when performed annually on asymptomatic women as part 
of a well-woman exam and continue to perform them routinely in the office. 
Research also shows that the majority of women do not feel uncomfortable 
or pain during a pelvic exam and the majority wish to continue having them 
performed on a regular basis.  Combinations of different screening 
methods such as pelvic examination with serum CA-125 annually and 
serum CA-125 with transvaginal ultrasound annually were found to be 
effective in screening for ovarian cancer in asymptomatic women.
Keywords: bimanual pelvic examination, pelvic exam, ovarian cancer 
screening, CA-125, transvaginal ultrasounds, gynecological screening, 
adnexal mass, asymptomatic women
• In asymptomatic women who receive Pap screenings every 3 or 5 years, 
are pelvic exams beneficial for ovarian cancer screening in comparison 
to no screening?  
• Do healthcare provider’s professional beliefs align with the evidence and 
national recommendations? 
• What are women’s thoughts and beliefs regarding pelvic examinations? 
• If pelvic exams are not beneficial, what other screening methods are 
available for ovarian cancer?
• Abenhaim, Titus-Ernstoff, & Cramer (2007) found that women with ovarian cancer were 
significantly less likely to have an annual medical visit and pelvic exam (Table 1)
• The Prostate, Lung, Colorectal and Ovarian cancer screening (PLCO) trial found 
sensitivity for ovarian palpation for cancer was 5.1%, specificity was 99.0%; pelvic 
exams were removed from the study after 5 years (Doroudi, Kramer, & Pinsky, 2016)
• The study conducted by Padilla, Radosevich, and Milad (2000) found adnexal masses 
with bimanual palpation 8% of the time (sensitivity was 15-33%, specificity was 79-92%) 
while women were under general anesthesia with a Foley placed
• The American College of Physicians (ACP) gives a strong recommendation to not 
perform pelvic exams on asymptomatic women based off low sensitivity, additional 
costs, and possible harm. Most literature that the recommendation is based on is >10 
years old (Qaseem, Humphrey, Harris, Starkey, & Denberg, 2014). 
• Henderson, Harper, Gutin, Saraiya, Chapman, & Sawaya (2013) surveyed ob/gyn
providers with 4 vignettes with asymptomatic women not needing a pap; nearly all would 
perform a pelvic exam (Figure 1) 
• Kling et al. (2017) found that 92.4% of women had pelvic exams performed on a regular 
basis either annually or every 2-5 years, and after reviewing the new ACP guidelines, 
86.7%  will continue regular pelvic exams 
• Combining serum CA-125, bimanual pelvic examination, and transvaginal ultrasound for 
ovarian cancer screening had 100% sensitivity, 99.7% specificity, and PPV of 22% 
which is effective for screening (Adonakis et al., 1996) (Table 2)
• The PLCO did not find that CA-125 or TVU screenings significantly reduces mortality but 
both have a higher sensitivity than pelvic exams; found a 35% reduction in mortality 
which was not statistically significant (p=0.05) (Buys et al., 2011)
• Van Nagell et al. (2007) found TVU had PPV of 27.1% and NPV of 99.9%. 
– Those with annual screenings with TVU and diagnosed with ovarian cancer had a 
92.1% 2-year survival rate in comparison with the general population with unknown or 
no screenings had a 2-year survival rate of 70.7%
– 82% of the women in the study with ovarian cancer were found in stage I or stage II 
compared to the general population of women diagnosed with stage I or II being 34%
• The UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) showed optimistic 
results by combining TVU and CA-125 with sensitivity of 89.4%, specificity of 99.8%, 
and PPV of 43.3% (Menon et al., 2009)
• Providers should discuss the potential risks and benefits of performing 
bimanual pelvic examinations and reach a mutual decision 
• Each woman should be treated as their own individual with all their 
medical history taken into account in the decision making
• It should not be assumed that bimanual exams do not need to be 
performed anymore nor that they should be performed annually 
without discussion
• If a woman does not wish to decide or would like professional advice, 
based on common practice of expert providers, it should be advised to 
perform them annually
• There are no other screening tests covered by insurance for ovarian 
cancer screening. Therefore, pelvic examinations with low sensitivity 
will remain standard practice until further studies, research, or 
guidelines suggest otherwise
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• 70% of ovarian cancer cases are diagnosed late, usually beyond the 
possibly of a cure (Chagas, E. & Brazil, A., 2016)
• Most women with tumors of the ovaries or fallopian tubes are 
asymptomatic and approximately 75% of ovarian cancer diagnoses are 
metastatic with poor survival rates even with treatment (Adonakis, 
Paraskevaidis, Tsiga, Seferiadis, & Lolis, 2016)
• Ovarian cancer that is found only in the ovary and has not metastasized 
has a 5-year survival rate of 92% compared to a 5-year survival rate of 
30% with metastatic ovarian cancer
• A screening tool with high sensitivity is important to detect these findings 
early
• Since the frequency of Pap tests has decreased, there has been much 
debate within the medical community on the frequency of pelvic 
examinations or if they are even beneficial at all in asymptomatic adult 
women
Table 1: Ovarian cancer risk based on medical visit frequency, pelvic examination, and type 
of healthcare provider  
Note. Adapted from “Ovarian cancer risk in relation to medical visits, pelvic examinations, and type 
of health care provider”, by H. A. Abenhaim, L. Titus-Ernstoff, and D. W. Cramer, 2007, Canadian 
Medical Association Journal, 176(7), p. 941-947. Copyright: 2007 by the Canadian Medical 
Association or its licensors.
Figure 1: Patient vignettes and thoughts of 
practitioners on pelvic exam 
Note. Adapted from “Routine bimanual pelvic examinations: 
Practices and beliefs of US obstetrician-gynecologists”, by J. 
T. Henderson, C. C. Harper, S. Gutin, M. Saraiya, J. 
Chapman, and G. F. Sawaya, 2013, American Journal of 
Obstetrics & Gynecology, 208, p. 109.e1-7. Copyright: 2013 
by Mosby, Inc. 
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Note: Adapted from “A combined approach for the early detection of ovarian cancer in asymptomatic 
women”, by G. L. Adonakis, E. Paraskevaidis, S. Tsiga, K. Seferiadis, and D. E. Lolis, 1996, European 
Journal of Obstetrics & Gynecology and Reproductive Biology, 65, p. 221-225. Copyright: 1996 by 
Elsevier Science Ireland Ltd.
Table 2: Specificity, sensitivity and positive predictive value
